Literature DB >> 18159557

A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents.

Kami Kandola1, Amy Lea, Wanda White, Maria Santos.   

Abstract

INTRODUCTION: During the past decade, a trend toward increasing cases of Bordetella pertussis in older children and adults has been witnessed in Canada. The National Advisory Committee on Immunization now recommends that the adult formulation of the acellular pertussis (adult dTap) vaccine combined with diphtheria and tetanus toxoids be substituted for diphtheria and tetanus toxoids alone for the 14- to 16-year-old booster dose. In October 2000, the government of the Northwest Territories was one of the first to adopt adult dTap into their territorial immunization program free of charge.
OBJECTIVE: To evaluate the effect of the acellular pertussis vaccine in children and adolescents on the epidemiology of pertussis in the Northwest Territories.
METHODS: Pertussis is a reportable disease in the Northwest Territories, and data on the incidence rates of pertussis are available from 1989 to 2004. The present study reviews pertussis cases during three four-year periods: the whole-cell vaccine era (1993 to 1996); the preadult dTap era (1997 to 2000); and the postadult dTap era (2001 to 2004).
RESULTS: The incidence of pertussis decreased from 18.0 cases per 10,000 population in 1993 to 0.2 cases per 10,000 population in 2004. The number of cases decreased from 186 to 129 to 19 cases in the three chronological time periods (ie, whole-cell vaccine era, preadult dTap era and postadult dTap era, respectively), with the most substantial reduction coming with the introduction of postadult dTap.
CONCLUSIONS: There appears to be a decrease in the incidence of pertussis with the targeted introduction of adult dTap in the Northwest Territories.

Entities:  

Keywords:  Acellular pertussis; Adolescent; Targeted; Vaccine

Year:  2005        PMID: 18159557      PMCID: PMC2095047          DOI: 10.1155/2005/642315

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  10 in total

1.  An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine.

Authors:  G De Serres
Journal:  Can Commun Dis Rep       Date:  2000-05-01

2.  The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.

Authors:  W John Edmunds; Marc Brisson; Alessia Melegaro; Nigel J Gay
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

Review 3.  Pertussis of adults and infants.

Authors:  C H Wirsing von König; S Halperin; M Riffelmann; N Guiso
Journal:  Lancet Infect Dis       Date:  2002-12       Impact factor: 25.071

4.  Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Authors:  Thuan Le; James D Cherry; Swei-Ju Chang; Maria Deloria Knoll; Martin L Lee; Steve Barenkamp; David Bernstein; Robert Edelman; Kathryn M Edwards; David Greenberg; Wendy Keitel; John Treanor; Joel I Ward
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

5.  Acellular pertussis vaccine for adolescents.

Authors: 
Journal:  Paediatr Child Health       Date:  2003-07       Impact factor: 2.253

6.  Unrecognized pertussis infection in adolescents.

Authors:  B A Cromer; J Goydos; J Hackell; J Mezzatesta; C Dekker; E A Mortimer
Journal:  Am J Dis Child       Date:  1993-05

7.  Pertussis in German adults.

Authors:  S Schmitt-Grohé; J D Cherry; U Heininger; M A Uberall; E Pineda; K Stehr
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

8.  Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis.

Authors:  Kenneth W Purdy; Joel W Hay; Marc F Botteman; Joel I Ward
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

9.  Pertussis in adults.

Authors:  T Aoyama; Y Takeuchi; A Goto; H Iwai; Y Murase; T Iwata
Journal:  Am J Dis Child       Date:  1992-02

10.  Bordetella pertussis infection: a cause of persistent cough in adults.

Authors:  P W Robertson; H Goldberg; B H Jarvie; D D Smith; L R Whybin
Journal:  Med J Aust       Date:  1987-05-18       Impact factor: 7.738

  10 in total
  2 in total

1.  The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Bull World Health Organ       Date:  2011-07-05       Impact factor: 9.408

2.  [Booster doses outside of the Expanded Program on Immunization in two schools in basic education in Yaounde, Cameroon].

Authors:  Clémence Vougmo Meguejio Njua; Félicitée Nguefack; David Chelo; Mathurin Tejiokem; Innocent Kago; Marie Kobela
Journal:  Pan Afr Med J       Date:  2011-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.